A Study on the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of SKB500 in Subjects With Advanced Solid Tumors
Clinical trial NCT06736327 · RECRUITING
Trial details
- NCT number
- NCT06736327
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-13
- Primary completion
- 2027-07-31
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.